Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Santos da Silva Jorge (CIK 1920509) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-13). Recent activity: Sell MLTX (33,936 shares), Sell MLTX (68,289 shares), Sell MLTX (47,775 shares), Sell MLTX (98,127 shares), Sell MLTX (51,873 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-13 | MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer | Sell | 33,936 | $679,059 |
| 2026-07-13 | MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer | Sell | 68,289 | $1.4M |
| 2026-07-02 | MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer | Sell | 47,775 | $956,933 |
| 2026-04-14 | MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer | Sell | 98,127 | $1.8M |
| 2026-04-14 | MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer | Sell | 51,873 | $945,645 |
| 2025-12-22 | MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer | Buy | 196,316 | $0 |
| 2025-12-22 | MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer | Sell | 196,316 | $0 |
| 2025-12-10 | MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer | Sell | 130,000 | $2.0M |
| 2025-12-10 | MoonLake Immunotherapeutics (MLTX) | Chief Executive Officer | Sell | 70,000 | $1.0M |
Source: SEC Form 4 filings · as of 2026-07-13